219 related articles for article (PubMed ID: 23955600)
1. Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.
Cama A; Verginelli F; Lotti LV; Napolitano F; Morgano A; D'Orazio A; Vacca M; Perconti S; Pepe F; Romani F; Vitullo F; di Lella F; Visone R; Mannelli M; Neumann HP; Raiconi G; Paties C; Moschetta A; Tagliaferri R; Veronese A; Sanna M; Mariani-Costantini R
Acta Neuropathol; 2013 Oct; 126(4):575-94. PubMed ID: 23955600
[TBL] [Abstract][Full Text] [Related]
2. Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas.
Merlo A; de Quiros SB; Secades P; Zambrano I; Balbín M; Astudillo A; Scola B; Arístegui M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2194-200. PubMed ID: 22977270
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
van Nederveen FH; Gaal J; Favier J; Korpershoek E; Oldenburg RA; de Bruyn EM; Sleddens HF; Derkx P; Rivière J; Dannenberg H; Petri BJ; Komminoth P; Pacak K; Hop WC; Pollard PJ; Mannelli M; Bayley JP; Perren A; Niemann S; Verhofstad AA; de Bruïne AP; Maher ER; Tissier F; Méatchi T; Badoual C; Bertherat J; Amar L; Alataki D; Van Marck E; Ferrau F; François J; de Herder WW; Peeters MP; van Linge A; Lenders JW; Gimenez-Roqueplo AP; de Krijger RR; Dinjens WN
Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic patterns in patients with the head-and-neck paragangliomas associate with differential clinical characteristics.
Chen H; Zhu W; Li X; Xue L; Wang Z; Wu H
J Cancer Res Clin Oncol; 2017 Jun; 143(6):953-960. PubMed ID: 28255624
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
[TBL] [Abstract][Full Text] [Related]
7. A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family-based study.
de Vos B; Rijken JA; Adank MA; Hoksbergen AWJ; Bayley JP; Leemans CR; Hensen EF
Clin Otolaryngol; 2018 Jun; 43(3):841-845. PubMed ID: 29292578
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.
Baysal BE; Willett-Brozick JE; Lawrence EC; Drovdlic CM; Savul SA; McLeod DR; Yee HA; Brackmann DE; Slattery WH; Myers EN; Ferrell RE; Rubinstein WS
J Med Genet; 2002 Mar; 39(3):178-83. PubMed ID: 11897817
[TBL] [Abstract][Full Text] [Related]
10. Hereditary paraganglioma targets diverse paraganglia.
Baysal BE
J Med Genet; 2002 Sep; 39(9):617-22. PubMed ID: 12205103
[TBL] [Abstract][Full Text] [Related]
11. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology.
Douwes Dekker PB; Hogendoorn PC; Kuipers-Dijkshoorn N; Prins FA; van Duinen SG; Taschner PE; van der Mey AG; Cornelisse CJ
J Pathol; 2003 Nov; 201(3):480-6. PubMed ID: 14595761
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal changes in sporadic and familial head and neck paragangliomas.
Sevilla MA; Hermsen MA; Weiss MM; Grimbergen A; Balbín M; Llorente JL; Rodrigo JP; Suárez C
Otolaryngol Head Neck Surg; 2009 May; 140(5):724-9. PubMed ID: 19393419
[TBL] [Abstract][Full Text] [Related]
13. Neck paraganglioma and follicular lymphoma: a case report.
Marchetti L; Perrucci L; D'Ercole F; Zatelli MC; Ambrosio MR; Giganti M; Carnevale A
J Med Case Rep; 2019 Dec; 13(1):376. PubMed ID: 31856921
[TBL] [Abstract][Full Text] [Related]
14. Head and neck paragangliomas: Report of 175 patients (1989-2010).
Papaspyrou K; Mewes T; Rossmann H; Fottner C; Schneider-Raetzke B; Bartsch O; Schreckenberger M; Lackner KJ; Amedee RG; Mann WJ
Head Neck; 2012 May; 34(5):632-7. PubMed ID: 21692132
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of paragangliomas of the skull base and head and neck region: implications for medical and surgical management.
Hussain I; Husain Q; Baredes S; Eloy JA; Jyung RW; Liu JK
J Neurosurg; 2014 Feb; 120(2):321-30. PubMed ID: 24236653
[TBL] [Abstract][Full Text] [Related]
17. Activation of the NOTCH pathway in head and neck cancer.
Sun W; Gaykalova DA; Ochs MF; Mambo E; Arnaoutakis D; Liu Y; Loyo M; Agrawal N; Howard J; Li R; Ahn S; Fertig E; Sidransky D; Houghton J; Buddavarapu K; Sanford T; Choudhary A; Darden W; Adai A; Latham G; Bishop J; Sharma R; Westra WH; Hennessey P; Chung CH; Califano JA
Cancer Res; 2014 Feb; 74(4):1091-104. PubMed ID: 24351288
[TBL] [Abstract][Full Text] [Related]
18. Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1α/miR-210 signaling pathway.
Merlo A; de Quirós SB; de Santa-María IS; Pitiot AS; Balbín M; Astudillo A; Scola B; Arístegui M; Quer M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1661-6. PubMed ID: 23902947
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations.
Heesterman BL; Bayley JP; Tops CM; Hes FJ; van Brussel BT; Corssmit EP; Hamming JF; van der Mey AG; Jansen JC
Eur J Hum Genet; 2013 Apr; 21(4):469-70. PubMed ID: 22948026
[TBL] [Abstract][Full Text] [Related]
20. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.
Bayley JP; Kunst HP; Cascon A; Sampietro ML; Gaal J; Korpershoek E; Hinojar-Gutierrez A; Timmers HJ; Hoefsloot LH; Hermsen MA; Suárez C; Hussain AK; Vriends AH; Hes FJ; Jansen JC; Tops CM; Corssmit EP; de Knijff P; Lenders JW; Cremers CW; Devilee P; Dinjens WN; de Krijger RR; Robledo M
Lancet Oncol; 2010 Apr; 11(4):366-72. PubMed ID: 20071235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
